0
The Global Fund:
           A Public-private Partnership to
               Fight Deadly Diseases



Professor Rifat Atun
D...
Presentation Structure

• Global Health Public Private Partnerships
• Segmentation
• The Global Fund
Total annual resources available for
                              AIDS: 1986-2008
    13                                 ...
Global Health Partnerships


Almost 100 in number
• New actors in the global health landscape
    –    Country governments...
Investment in GHPPP (received) by 2007
                                                                                   ...
• Global Health Public Private Partnerships
• Segmentation
• The Global Fund
Segmenting Global Health PPPs (1)
Segmenting Global Health PPPs (2)
Push Mechanisms: Product Development
             Partnerships

• Global Alliance for TB Drug Development (TB
  Alliance)
...
Number of GHPPP along the R&D value
              chain
Number of GHPPPs along the R&D value
        chain by disease area
Push Mechanisms: Product Access
              Partnerships

• Global Alliance for the Elimination of Lymphatic
  Filariasi...
Pull Mechanisms: Global Financing
                Institutions


• The Global Fund to Fight AIDS, Tuberculosis and
  Malar...
• Global Health Public Private Partnerships
• Segmentation
• The Global Fund
Scaling up in investment

By September 2009          Proportion of External
                             Global Investment...
Accelerating Scale Up

                            5.0                                         75
                        ...
Affordable Medicines Facility – malaria
 Multiple eligible                                                                ...
1 4 Atun Insead Vf 4 10 09
1 4 Atun Insead Vf 4 10 09
1 4 Atun Insead Vf 4 10 09
Upcoming SlideShare
Loading in...5
×

1 4 Atun Insead Vf 4 10 09

702

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
702
On Slideshare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
3
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Transcript of "1 4 Atun Insead Vf 4 10 09"

  1. 1. The Global Fund: A Public-private Partnership to Fight Deadly Diseases Professor Rifat Atun Director, Strategy, Performance and Evaluation Cluster
  2. 2. Presentation Structure • Global Health Public Private Partnerships • Segmentation • The Global Fund
  3. 3. Total annual resources available for AIDS: 1986-2008 13 13 12 11 10 10 9 8297 Signing 2001 UN 8 US$ Billion Declaration of Commitment 7 on HIV/AIDS (UNGASS ) 6 5 World Bank 4 MAP launch UNAIDS PEPFAR 3 Less than US$ 1 million 2 1623 Global Fund 212 257 292 1 59 0 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 Notes: [1] 1986-2000 figures are for international funds only [2] Domestic funds are included from 2001 onwards
  4. 4. Global Health Partnerships Almost 100 in number • New actors in the global health landscape – Country governments (donors and recipients), philanthropy (e.g. Gates), Private Sector, Pharma, Med Tech and Civil Society • New global governance mechanisms – Transcend traditional multilateral institutions
  5. 5. Investment in GHPPP (received) by 2007 Foundations – Multilateral Agencies - Private Governments 12000 10000 8000 6000 4000 US$ Millions 2000 250 200 150 100 50 0 ip ip ce sh S TM l er H sh P i I er I TH ta I V D I A R M D V tn V A R V tn W an A M N D To IP A N ar D R M ID FA H A a rIO FI TB T M lli G P P D E C P A G A P B TB -T R p D to M S ll y Li
  6. 6. • Global Health Public Private Partnerships • Segmentation • The Global Fund
  7. 7. Segmenting Global Health PPPs (1)
  8. 8. Segmenting Global Health PPPs (2)
  9. 9. Push Mechanisms: Product Development Partnerships • Global Alliance for TB Drug Development (TB Alliance) • International AIDS Vaccine Initiative (IAVI) • International Partnership for Microbicides (IPM) • Malaria Vaccine Initiative (MVI) • Medicines for Malaria Venture (MMV) • Microbicide Development Programme (MDP)
  10. 10. Number of GHPPP along the R&D value chain
  11. 11. Number of GHPPPs along the R&D value chain by disease area
  12. 12. Push Mechanisms: Product Access Partnerships • Global Alliance for the Elimination of Lymphatic Filariasis • Global Polio Eradication Initiative (GPEI) • International Trachoma Initiative (ITI) • Malarone Donation Program • Mectizan Donation Program • WHO/Novartis Coartem® (Coartem)
  13. 13. Pull Mechanisms: Global Financing Institutions • The Global Fund to Fight AIDS, Tuberculosis and Malaria (The Global Fund) • Global Alliance for Vaccines and Immunization (GAVI Alliance)
  14. 14. • Global Health Public Private Partnerships • Segmentation • The Global Fund
  15. 15. Scaling up in investment By September 2009 Proportion of External Global Investment (2008) • Total pledges $21.2 Bn • 23% of HIV • Approved ~ $16.2 Bn • 60% of TB • Disbursed ~ $8.6 Bn • 75% of Malaria (142 countries and ~ 600 grants)
  16. 16. Accelerating Scale Up 5.0 75 70 4.5 DOTS 65 ARV 4.0 60 ITNs ARV and DOTS (millions) 55 3.5 50 3.0 45 ITN (millions) 40 2.5 35 2.0 30 25 1.5 20 1.0 15 10 0.5 5 0.0 - 2004 2005 2006 2007 2008
  17. 17. Affordable Medicines Facility – malaria Multiple eligible Co-payment ACT manufacturers First line Private NGO Buyers Public Buyers buyers Buyers (e.g. PSI, MSF) (e.g. Ministry of (e.g. National Health) Wholesalers) Wholesalers Distributors Central medical stores Medicines Money Retailers, private clinics and public providers Patients
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×